Monash scientists have shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours.
Scientists from the Biomedicine Discovery Institute (BDI) showed that a single dose of the drug, Ivermectin, could stop the SARS-CoV-2 virus growing in cell culture. Read the full story on the Monash Biomedicine Discovery Institute (BDI) website.
This Monash University-led collaborative study was published in Antiviral Research, a peer-reviewed medical journal published by Elsevier. Read the full manuscript here.
Whilst shown to be effective in the lab environment, Ivermectin cannot be used in humans for COVID-19 until further testing and clinical trials have been completed to confirm the effectiveness of the drug at levels safe for human dosing. The potential use of Ivermectin to combat COVID-19 remains unproven, and depends on funding to progress the work into the next stages.
For any medical questions you have about your health, please consult your health care provider.